Actinium Pharmaceuticals (NYSE: ATNM) SIERRA Trial Study
Автор: Actinium Pharmaceuticals
Загружено: 17 июн. 2021 г.
Просмотров: 220 просмотров
The SIERRA Trial is a study of a novel agent that incorporates targeted radiation as part of the conditioning regimen for stem cell or BMT, which has “worked very well to get patients into remission,” Stuart Seropian, MD, explained.

Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: